Correction to: Neuropsychopharmacology https://doi.org/10.1038/s41386-022-01421-2, published online 13 September 2022
The technical name of the compound studied in this article was incorrectly referred to as SEP-383856 in the title and the abstract and has now been corrected to SEP-363856. None of the scientific conclusions in this paper are affected by this correction. The original article has been corrected.
About this article
Cite this article
Saarinen, M., Mantas, I., Flais, I. et al. Correction To: TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP- 363856. Neuropsychopharmacol. (2022). https://doi.org/10.1038/s41386-022-01504-0